Oncodisc

Oncodisc provides the first implantable vascular access port with biosensors and wireless communication, combined with a remote digital healthcare platform designed by oncologists, offering new tools for patients and doctors to improve outcomes through remote monitoring and data analysis while optimizing the delivery of low-cost medical services. The system developed by the company enhances cancer treatment by integrating implantable medical devices, remote monitoring, and data analysis. Oncodisc was co-founded by experienced physician entrepreneurs James Mitchell, M.D., and Andrew Thoreson, M.D.